Hebei Lansheng Biotech Co., Ltd.
Beijing Multigrass Formulation Co., Ltd.

ABA Chemicals investing in a tetraniliprole and triflumezopyrim project in Hubei Province, Chinaqrcode

May. 15, 2020

Favorites Print
Forward
May. 15, 2020
On May 7, journalist learned from Xiangyang Xiangcheng District Investment Promotion Center, China’s Hubei Province, that a pharmaceutical intermediates project invested in by Shanghai ABA Chemicals for Yuan500 million, is being set up in Xiangcheng. 
 
Phase one of the amide intermediates project in Xiangcheng covers newly built workshops and supporting facilities for the production of tetraniliprole, triflumezopyrim and etc. After the completion of the project, the annual production value is expected to reach Yuan500 million, with an annual tax contribution of Yuan25 million.
 
The project, launched by ABA Chemicals this time and chosen to be set up in Xiangcheng, is a complete recognition of Xiangcheng's pharma-chemical industrial strength. The project is expected to further promote the transformation and upgrading of Xiangcheng's pharma-chemical industry through the joint efforts of all the relevant parties. 
 
Source: AgroNews

Picture 0/1200

More from AgroNews

Magazine

2020 Latin America Focus 2020 Biologicals Special
2020 Formulation & Adjuvant Technology Annual Review 2019
Chinese issue of Annual Review 2019 2019 CRO & CRAO Manual
I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

Picture 0/1200

Subscribe to daily email alerts of AgroNews.